Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Company

‘I’ve been surviving on handouts’: Chaos as 120,000 UK drivers left stranded by ‘do not drive’ cars

One mother shares how she is struggling visit her premature son is hospital after rare ‘do not drive’ order

The Independent UK

Warner Bros Discovery Q2 FY2025 Earnings Call Transcript

Warner Bros. Discovery Inc (NASDAQ:WBD) reported its second-quarter 2025 financial results ahead of the opening bell on Thursday.

Benzinga

Super Micro Computer Q4 FY2025 Earnings Call Transcript

Super Micro Computer Inc. (NASDAQ:SMCI) reported fourth-quarter financial results after market close on Tuesday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Alien: Earth review: 'instant TV classic splices body horror with AI angst'

5/5 This new series on Disney is a prequel to the original Ridley Scott film that both echoes its brilliance and takes the Alien franchise into new territory to tackle contemporary tech angst

Evening Standard

This Cancer Biotech Company Is Making a Big Bet on the HYPE Crypto. Should You Buy Its Stock Here?

Sonnet Bio is pivoting towards becoming a crypto treasury company by accumulating the HYPE Crypto.

Barchart

Parent company of Trump’s Truth Social posts $20 million loss

Sales were under $1 million, but the company is cash rich thanks to Bitcoin.

Fortune

Stock Of The Day: New Downtrend For Boeing?

The Boeing Company (NYSE:BA) is trending lower Thursday. This comes after the company reported its earnings Tuesday. At first, investors liked what they heard and the stock rallied. But it quickly reversed and is now much lower.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Mastercard Stock Jumps After Strong Q2: Travel Spending, Digital Services Fuel Revenue Beat And Raised Outlook

Mastercard (NYSE: MA) reported fiscal second-quarter results on Thursday. The company reported quarterly net revenues of $8.13 billion, up 17% year-over-year and 16% Y/Y on a neutral currency basis, beating the analyst consensus estimate of $7.95 billion.

Benzinga

PowerBank and Intellistake Announce Strategic Alliance to Pioneer Digital Currencies, including Bitcoin Treasury Integration and RWA Tokenization

Highlights of the Partnership:

International Business Times

Trump Media (DJT) Stock Pulls Back, Consolidating Recent Crypto-Fueled Gains

Shares of Trump Media Technology Group Corp (NASDAQ:DJT) are experiencing a slight pullback in Thursday morning trading, appearing to consolidate after a rally earlier this week. The stock's recent surge was driven by major announcements regarding the company’s new cryptocurrency strategy.

Benzinga

Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in pre-market trading after the company announced it will engage in strategic restructuring and cost savings.

Benzinga

Bank Of America Q2 Earnings Preview: Can Top Warren Buffett Holding Keep Beating Analyst Estimates?

Bank of America Corporation (NYSE:BAC) looks to keep a streak of beating analyst estimates alive when the company reports second-quarter financial results before the market opens Wednesday.

Benzinga

Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors

The company will likely focus on off-loading smaller beauty brands.

Fortune

External Contributors Policy

Terms & conditions for freelancers and other contributors of content including user comments.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

RideApart

Something Weird Is Happening at LiveWire. What's Up With Its Stock?

It's no secret that EV motorcycle maker LiveWire has been having a rough time. But then its value suddenly got higher than it had in months, and many stocks got sold.

The National (Scotland)

Cavenagh & 49ers Enterprises' £20m Rangers investment approved at EGM

Andrew Cavenagh & 49ers Enterprises' £20m Rangers investment approved at EGM

International Business Times

Universal Digital Inc. Announces Bitcoin Treasury Strategy Across North America And Asia

Vancouver, Canada, June 16th, 2025, Chainwire

Barchart

How Is Amgen's Stock Performance Compared to Other Pharmaceuticals Stocks?

Amgen has underperformed the Pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

PC Gamer

Lethal Company's biggest update for months is finally out, and with it comes the much awaited first look at a new monster

Look out for the Sapsucker on Vow.

The National (Scotland)

Rangers EGM details confirmed as special resolutions set after US takeover

International Business Times

Jeep Owner Stellantis Names Italian Antonio Filosa As New CEO

Auto giant Stellantis, whose brands include Jeep, Peugeot and Fiat, on Wednesday named company veteran Antonio Filosa as its new chief executive officer as the US-European group navigates US tariffs and slumping North American sales.

The Guardian - AU

Disability services provider which collapsed with $500,000 tax debt investigated by NDIS regulator

Exclusive: Residents asked to sign contracts with a new company operated by a relative of Core & Capacity’s director after it was declared insolvent

Barchart

Becton, Dickinson and Company Stock: Analyst Estimates & Ratings

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

The Guardian - UK

Murderbot review – Alexander Skarsgård is hella cool as a bored Robocop who hates all humans

This space comedy is about a cyborg who reprograms himself to go rogue … then just wants to mock stupid humans and glob out in front of the telly. It’s such a funny premise – but sadly falls short

Barchart

This Pharma Stock Is Still a ‘Strong Buy’ Despite Trump’s Plans to Lower Drug Prices

Despite Trump’s executive order to cut drug prices, Eli Lilly’s stock surged, showing strong resilience and impressive gains amidst regulatory concerns.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

851 stories

815 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.